Public Relations for Psychedelics & NeuroWellness

With the mental health industry projected to reach over $6 billion by 2027, it’s important to consider an effective communications strategy to stand out in this space.

As experts in the quickly growing Psychedelics and NeuroWellness industries, Durée & Company is a trusted partner to your brand. Representing clients across all facets of the industry, our team creates a customized and comprehensive plan that amplifies your brand story and delivers key messaging directly into the hands of your target audience.

Breaking down the stigma, psychedelic medicine has now been recast as a therapeutic solution to a range of mental health conditions.

In this emerging marketplace, companies are developing medicines from psilocybin, MDMA, ibogaine and LSD, all of which are currently illegal in the US. Ketamine, an anesthetic with hallucinogenic properties, is quickly gaining ground as it is currently the only legal psychedelic compound available in the US. Having caught the attention of startups and investors, psychedelic medicine has become an industry disruptor with proven results to treat PTSD, anxiety, addiction, depression, trauma and pain. With new developments every day, our team proactively identifies opportunities for clients to have a share of voice, become thought leaders, and solidify their presence in this rapidly expanding community.

Durée & Company offers services in PR, social media and marketing for these emerging markets, including strategic public relations support, content marketing, innovative branding, in-depth media outreach, and the development of corporate social responsibility (CSR) initiatives. Our team regularly attends conferences, webinars and other learning opportunities where we can engage with experts. Our proven psychedelic science, psychedelic-assisted therapy and psychedelic venture capital and private equity public relations outreach has placed clients in notable media outlets including The Wall Street Journal, Forbes, Fox Business, Green Entrepreneur, DoubleBlind, Page Six, VICE, and many other leading publications. Our established presence in the industry and deep-rooted relationships with media, influencers and thought leaders allows us to bring opportunities to our clients that set them apart from the competition.

If you are a Psychedelics or NeuroWellness brand, you can trust Durée & Company as your public relations partner.


“Durée & Company has been an invaluable asset since day one. Not only do they understand the emerging psychedelic space and the intricacies of launching and promoting a venture capital fund, but they’ve also provided meaningful counsel. They have put forth ideas and timelines that have helped us effectively communicate, which has positively impacted our business. We are fortunate to work with an agency that is passionate about client service and goes above and beyond what is expected. I wouldn’t be where I am without Durée!”


We have found a true partnership with Durée & Company. As a growing business in the psychedelics industry, we were seeking an agency that understood our industry and could bring more visibility to our company. Durée & Company has brought us opportunities that have directly impacted our business. From national TV segments to social media and blog content that reaches our target audiences, we are so pleased with the work. Durée & Company always goes the extra mile and takes the time to talk through the big picture strategy with us as we continue to grow.

Recent Psychedelics & NeuroWellness Blogs

2023: The Year of the Mushroom

2023: The Year of the Mushroom

We at Durée & Company – a Fort Lauderdale- and Aspen-based public relations and marketing agency – predict that 2023 will be the year of the mushroom!…
Press Releases
Benzinga Brings Nation’s Top Psychedelics Business, Investing Conference Back To Miami Beach April 13
Press Releases
Entrepreneurs Christina Thomas and Charles Patti of MY Self Wellness to Appear on CNBC’s “Money Court” on Dec. 21
Press Releases
Mr. Cannabis Law Serves as Lead Counsel for KetaMD, Assisting with the Acquisition by Braxia Scientific Corp.
Press Releases
MY Self Wellness Ketamine Clinic Launches Nonprofit Organization Warriors of Consciousness, Helping Those Who Cannot Afford Psychedelic Ketamine Therapy Treatments
Press Releases
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers
The Mushroom Moment: Pop Culture Trends in the Psychedelics Industry
Press Releases
Mr. Psychedelic Law Appoints Courtney Barnes as Lead Drafter for Florida’s Next Psychedelic Research and Therapeutic Access Bill
Press Releases
Iter Investments Announces the Closing of its First Fund After a Successful Round of Funding and Deploying Capital in the Emerging Psychedelic Market
mental health
PR Tools
Public Relations for Psychedelics: Raising Mental Health and PTSD Awareness

What else should you know about us? Contact the team at Durée & Company to find out.